Using CD39/CD103 to Isolate Tumor-Reactive CD8 TIL: Bench to Bedside

Authors

AD Weinberg, Providence

Document Type

Presentation

Publication Date

10-3-2023

Keywords

oregon; chiles

Clinical Institute

Cancer

Clinical Institute

Neurosciences (Brain & Spine)

Comments

TIL Therapies Summit; 2023 October 3; Boston, MA

Recommended Citation

Weinberg, AD, "Using CD39/CD103 to Isolate Tumor-Reactive CD8 TIL: Bench to Bedside" (2023). Articles, Abstracts, and Reports. 8037.
https://digitalcommons.providence.org/publications/8037